{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:47:45Z","timestamp":1791229665216,"version":"4.1.0"},"reference-count":104,"publisher":"Microbiology Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,2,1]]},"DOI":"10.1099\/jmm.0.45753-0","type":"journal-article","created":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T04:17:36Z","timestamp":1106713056000},"page":"101-111","source":"Crossref","is-referenced-by-count":124,"title":["Alternative treatments for Clostridium difficile disease: what really works?"],"prefix":"10.1099","volume":"54","author":[{"given":"Lynne V","family":"McFarland","sequence":"first","affiliation":[{"name":"University of Washington, HSR&D, 1100 Olive Street, #1400, Seattle, WA 98101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"H1-2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/ajhp\/55.13.1407","article-title":"ASHP therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile -associated disease","volume":"55","year":"1998","journal-title":"Am J Health-Syst Pharm"},{"key":"H2-2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/342334","article-title":"Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature","volume":"35","author":"Apisarnthanarak","year":"2002","journal-title":"Clin Infect Dis"},{"key":"H3-2","first-page":"1049","article-title":"The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis","volume":"142","author":"Ariano","year":"1990","journal-title":"Can Med Assoc J"},{"key":"H4-2","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/JCM.38.6.2386-2388.2000","article-title":"Epidemiology of recurrences or reinfections of Clostridium difficile -associated diarrhea","volume":"38","author":"Barbut","year":"2000","journal-title":"J Clin Microbiol"},{"key":"H5-2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/gut.51.3.456","article-title":"Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea","volume":"51","author":"Beales","year":"2002","journal-title":"Gut"},{"key":"H6-2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0002-9629(15)40762-1","article-title":"Convulsions induced by metronidazole treatment for Clostridium difficile- associated disease in chronic renal failure","volume":"319","author":"Beloosesky","year":"2000","journal-title":"Am J Med Sci"},{"key":"H7-2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(86)92559-6","article-title":"Is Clostridium difficile endemic in chronic-care facilities?","volume":"2","author":"Bender","year":"1986","journal-title":"Lancet"},{"key":"H8-2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/00017285-199611001-00011","article-title":"Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG","volume":"31","author":"Bennett","year":"1996","journal-title":"Nutr Today"},{"key":"H9-2","first-page":"1","article-title":"& 9 other authors","volume":"56 Suppl 1","author":"Berrington","year":"2004","journal-title":"J Hosp Infect"},{"key":"H10-2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00005176-199508000-00016","article-title":"Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG","volume":"21","author":"Biller","year":"1995","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"H11-2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gut.27.10.1169","article-title":"Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic-associated colitis due to Clostridium difficile","volume":"27","author":"Bolton","year":"1986","journal-title":"Gut"},{"key":"H12-2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1086\/368080","article-title":"Safety of probiotics that contain lactobacilli or bifidobacteria","volume":"36","author":"Borrelio","year":"2003","journal-title":"Clin Infect Dis"},{"key":"H13-2","first-page":"178","article-title":"Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis","volume":"47","author":"Bowden","year":"1981","journal-title":"Am Surg"},{"key":"H14-2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/bjs.1800840205","article-title":"Surgical aspects of Clostridium difficile colitis","volume":"84","author":"Bradbury","year":"1997","journal-title":"Br J Surg"},{"key":"H15-2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2307\/30145487","article-title":"Risk factors for Clostridium difficile toxin-associated diarrhea","volume":"11","author":"Brown","year":"1990","journal-title":"Infect Control Hosp Epidemiol"},{"key":"H16-2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004836-198704000-00009","article-title":"Therapy of relapsing Clostridium difficile -associated diarrhea and colitis with the combination of vancomycin and rifampin","volume":"9","author":"Buggy","year":"1987","journal-title":"J Clin Gastroenterol"},{"key":"H17-2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF01666909","article-title":"Clostridium difficile : the epidemiology and prevention of hospital-acquired infection","volume":"10","author":"Burdon","year":"1982","journal-title":"Infection"},{"key":"H18-2","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/IAI.64.12.5225-5232.1996","article-title":"Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum","volume":"64","author":"Castagliuolo","year":"1996","journal-title":"Infect Immun"},{"key":"H19-2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/infdis\/166.3.561","article-title":"Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection","volume":"166","author":"Clabots","year":"1992","journal-title":"J Infect Dis"},{"key":"H20-2","article-title":"A phase 2 study of the toxin binding polymer Tolevamer in patients with Clostridium difficile -associated diarrhea","author":"Davidson","year":"2004","journal-title":"In First International Clostridium difficile Symposium, Slovenia. 5\u20138 May 2004"},{"key":"H21-2","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.36.10.2192","article-title":"Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile -associated diarrhea","volume":"36","author":"de Lalla","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"H22-2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02013056","article-title":"Epidemiology and prevention of Clostridium difficile infections in a leukemia unit","volume":"6","author":"Delmee","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"H23-2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1086\/422002","article-title":"The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens","volume":"39","author":"Donskey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"H24-2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archinte.1986.00360180083015","article-title":"Oral bacitracin vs vancomycin therapy for Clostridium difficile -associated diarrhea.A randomized double-blind trial","volume":"146","author":"Dudley","year":"1986","journal-title":"Arch Intern Med"},{"key":"H25-2","first-page":"739","article-title":"Guidelines for the diagnosis and management of Clostridium difficile -associated diarrhea and colitis","volume":"92","author":"Fekety","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"H26-2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9343(89)90223-4","article-title":"Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens","volume":"86","author":"Fekety","year":"1989","journal-title":"Am J Med"},{"key":"H27-2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/clinids\/24.3.324","article-title":"Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial","volume":"24","author":"Fekety","year":"1997","journal-title":"Clin Infect Dis"},{"key":"H28-2","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/clinids\/20.6.1560","article-title":"Bacteremia due to Clostridium difficile : case report and review of extraintestinal Clostridium difficile infections","volume":"20","author":"Feldman","year":"1995","journal-title":"Clin Infect Dis"},{"key":"H29-2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00004836-200405000-00005","article-title":"Factors associated with failure of metronidazole in Clostridium difficile -associated disease","volume":"38","author":"Fernandez","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"H30-2","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/BF02234641","article-title":"Intravenous metronidazole for the treatment of Clostridium difficile colitis","volume":"44","author":"Friedenberg","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"H31-2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/501562","article-title":"Enteric carriage of vancomycin-resistant Enterococcus faecium in patients tested for Clostridium difficile","volume":"20","author":"Garbutt","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"H32-2","first-page":"127","article-title":"Treatment of Clostridium difficile -associated diarrhea and colitis","volume":"250","author":"Gerding","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"key":"H33-2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2307\/30141083","article-title":"Clostridium difficile -associated diarrhea and colitis","volume":"16","author":"Gerding","year":"1995","journal-title":"Infect Control Hosp Epidemiol"},{"key":"H34-2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(87)92646-8","article-title":"Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG","volume":"2","author":"Gorbach","year":"1987","journal-title":"Lancet"},{"key":"H35-2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/JCM.41.1.509-511.2003","article-title":"Clostridium difficile brain empyema after prolonged intestinal carriage","volume":"41","author":"Gravisse","year":"2003","journal-title":"J Clin Microbiol"},{"key":"H36-2","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1093\/clinids\/20.Supplement_2.S266","article-title":"Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii","volume":"20","author":"Hassett","year":"1995","journal-title":"Clin Infect Dis"},{"key":"H37-2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/infdis\/169.6.1291","article-title":"Oligosaccharide sequences attached to an inert support (SYNSORB) as potential therapy for antibiotic-associated diarrhea and pseudomembranous colitis","volume":"169","author":"Heerze","year":"1994","journal-title":"J Infect Dis"},{"key":"H38-2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s100960050003","article-title":"Possible role of catheters in Saccharomyces boulardii fungemia","volume":"19","author":"Hennequin","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"H39-2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1086\/520284","article-title":"Epidemiology, appropriateness, and cost of vancomycin use","volume":"26","author":"Jarvis","year":"1998","journal-title":"Clin Infect Dis"},{"key":"H40-2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/159.2.340","article-title":"Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism","volume":"159","author":"Johnson","year":"1989","journal-title":"J Infect Dis"},{"key":"H41-2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0140-6736(90)91605-A","article-title":"Nosocomial Clostridium difficile colonization and disease","volume":"336","author":"Johnson","year":"1990","journal-title":"Lancet"},{"key":"H42-2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-117-4-297","article-title":"Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metrodindazole.A randomized, placebo-controlled trial","volume":"117","author":"Johnson","year":"1992","journal-title":"Ann Intern Med"},{"key":"H43-2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/313955","article-title":"Metronidazole resistance in Clostridium difficile","volume":"31","author":"Johnson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"H44-2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s002849900103","article-title":"Relapses or reinfections: analysis of a case of Clostridium difficile associated colitis by two typing systems","volume":"33","author":"Kato","year":"1996","journal-title":"Curr Microbiol"},{"key":"H45-2","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/bmj.2.6153.1667","article-title":"& 7 other authors","volume":"2","author":"Keighley","year":"1978","journal-title":"Br Med J"},{"key":"H46-2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0196-6553(90)90233-I","article-title":"Control of Clostridium difficile colitis outbreak by treating asymptomatic carriers with metronidazole","volume":"18","author":"Kerr","year":"1990","journal-title":"Am J Infect Control"},{"key":"H47-2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0195-6701(03)00115-4","article-title":"Impact of changes in antibiotic policy on Clostridium difficile -associated diarrhoea (CDAD) over a five-year period in a district general hospital","volume":"54","author":"Khan","year":"2003","journal-title":"J Hosp Infect"},{"key":"H48-2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ageing\/28.2.107","article-title":"Factors associated with prolonged symptoms and severe disease due to Clostridium difficile","volume":"28","author":"Kyne","year":"1999","journal-title":"Age Ageing"},{"key":"H49-2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(00)03592-3","article-title":"Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhea","volume":"357","author":"Kyne","year":"2001","journal-title":"Lancet"},{"key":"H50-2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/338260","article-title":"Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile","volume":"34","author":"Kyne","year":"2002","journal-title":"Clin Infect Dis"},{"key":"H51-2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0196-6553(95)90038-1","article-title":"The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study","volume":"23","author":"Lam","year":"1995","journal-title":"Am J Infect Control"},{"key":"H52-2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3476(05)83393-1","article-title":"Treatment with intravenously administered gamma globulin of chronic relapsing colitis inducted by Clostridium difficile toxin","volume":"118","author":"Leung","year":"1991","journal-title":"J Pediatr"},{"key":"H53-2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jac\/27.1.55","article-title":"Time-dependent killing of Clostridium difficile by metronidazole and vancomycin","volume":"27","author":"Levett","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"H54-2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004836-199604000-00007","article-title":"Whole-bowel irrigation as an adjunct to the treatment of chronic, relapsing Clostridium difficile colitis","volume":"22","author":"Liacouras","year":"1996","journal-title":"J Clin Gastroenterol"},{"key":"H55-2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/BF02044130","article-title":"Clostridium difficile infection as a cause of severe sepsis","volume":"22","author":"Lowenkron","year":"1996","journal-title":"Intensive Care Med"},{"key":"H56-2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/ageing\/28.6.578","article-title":"An antibiotic policy associated with reduced risk of Clostridium difficile -associated diarrhoea","volume":"28","author":"Ludlam","year":"1999","journal-title":"Age Ageing"},{"key":"H57-2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1086\/318149","article-title":"Environmental control to reduce transmission of Clostridium difficile","volume":"31","author":"Mayfield","year":"2000","journal-title":"Clin Infect Dis"},{"key":"H58-2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/089106000435446","article-title":"A review of the evidence of health claims for biotherapeutic agents","volume":"12","author":"McFarland","year":"2000a","journal-title":"Microb Ecol Health Dis"},{"key":"H59-2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/08910600050216183","article-title":"Normal flora: diversity and functions","volume":"12","author":"McFarland","year":"2000b","journal-title":"Microb Ecol Health Dis"},{"key":"H60-2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1056\/NEJM198901263200402","article-title":"Nosocomial acquisition of Clostridium difficile infection","volume":"320","author":"McFarland","year":"1989","journal-title":"N Engl J Med"},{"key":"H61-2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/infdis\/162.3.678","article-title":"Risk factors for Clostridium difficile carriage and C.difficile -associated diarrhea in a cohort of hospitalized patients","volume":"162","author":"McFarland","year":"1990","journal-title":"J Infect Dis"},{"key":"H62-2","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/jama.1994.03510480037031","article-title":"& 10 other authors","volume":"271","author":"McFarland","year":"1994","journal-title":"JAMA"},{"key":"H63-2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1086\/501553","article-title":"Recurrent Clostridium difficile disease: epidemiology and clinical characteristics","volume":"20","author":"McFarland","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"H64-2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005176-200009000-00004","article-title":"Pediatric Clostridium difficile : a phantom menace or clinical reality?","volume":"31","author":"McFarland","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"H65-2","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","article-title":"Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease","volume":"97","author":"McFarland","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"H66-2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/bjs.1800690306","article-title":"Randomized controlled trial of colestipol in antibiotic-associated colitis","volume":"69","author":"Mogg","year":"1982","journal-title":"Br J Surg"},{"key":"H67-2","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/j.1572-0241.1998.00541.x","article-title":"Clostridium difficile colitis: factors influencing treatment failure and relapse \u2013 a prospective evaluation","volume":"93","author":"Nair","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"H68-2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3748\/wjg.v10.i5.765","article-title":"& 7 other authors","volume":"10","author":"Nomura","year":"2004","journal-title":"World J Gastroenterol"},{"key":"H69-2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2307\/30145589","article-title":"Ten years of prospective Clostridium difficile -associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991","volume":"15","author":"Olson","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"key":"H70-2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/AAC.28.6.847","article-title":"Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestryramine","volume":"28","author":"Pantosti","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"H71-2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7326\/0003-4819-120-4-199402150-00003","article-title":"Decrease in nosocomial Clostridium difficile -associated diarrhea by restricting clindamycin use","volume":"120","author":"Pear","year":"1994","journal-title":"Ann Intern Med"},{"key":"H72-2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.46.6.1647-1650.2002","article-title":"Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin","volume":"46","author":"Pelaez","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"H73-2","first-page":"3283","article-title":"Treatment of recurrent Clostridium difficile -associated diarrhea by administration of donated stool directly through a colonoscope","volume":"95","author":"Persky","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"H74-2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0002-9270(99)00809-6","article-title":"The effect of probiotics on Clostridium difficile diarrhea","volume":"95","author":"Pochapin","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"H75-2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF01690732","article-title":"Chronic septic arthritis and osteomyelitis in a prosthetic knee joint due to Clostridium difficile","volume":"14","author":"Pron","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"H76-2","first-page":"175","article-title":"Multiple relapses of Clostridium difficile -associated diarrhea responding to an extended course of cholestryamine","volume":"8","author":"Pruksananonda","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"H77-2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5694\/j.1326-5377.1983.tb104346.x","article-title":"Diarrhoea associated with Clostridium difficile in a hospital population","volume":"1","author":"Riley","year":"1983","journal-title":"Med J Aust"},{"key":"H78-2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.anaerobe.2003.09.002","article-title":"Binary toxin producing Clostridium difficile strains","volume":"9","author":"Rupnik","year":"2003","journal-title":"Anaerobe"},{"key":"H79-2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/gut.41.3.366","article-title":"Intravenous immunoglobulin therapy for severe Clostridium difficile colitis","volume":"41","author":"Salcedo","year":"1997","journal-title":"Gut"},{"key":"H80-2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/anae.1999.0268","article-title":"Metronidazole susceptibility in Clostridium difficile isolates recovered from cases of C.difficile -associated disease treatment failures and successes","volume":"5","author":"Sanchez","year":"1999","journal-title":"Anaerobe"},{"key":"H81-2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/00365548409087145","article-title":"Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces","volume":"16","author":"Schwan","year":"1984","journal-title":"Scand J Infect Dis"},{"key":"H82-2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/jhin.2000.0770","article-title":"The rise of Clostridium difficile : the effect of length of stay, patient age and antibiotic use","volume":"45","author":"Shek","year":"2000","journal-title":"J Hosp Infect"},{"key":"H83-2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(97)08062-8","article-title":"Primary symptomless colonization by Clostridium difficile and decreased risk of subsequent diarrhoea","volume":"351","author":"Shim","year":"1998","journal-title":"Lancet"},{"key":"H84-2","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1086\/318130","article-title":"& 8 other authors","volume":"31","author":"Surawicz","year":"2000","journal-title":"Clin Infect Dis"},{"key":"H85-2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/00365549409011800","article-title":"Treatment of Clostridium difficile -associated diarrhea and colitis with an oral preparation of teicoplanin; a dose finding study","volume":"26","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"H86-2","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1128\/JCM.41.7.3413-3414.2003","article-title":"Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent Clostridium difficile -associated diarrhea","volume":"41","author":"Tang-Feldman","year":"2003","journal-title":"J Clin Microbiol"},{"key":"H87-2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/infdis\/141.1.92","article-title":"Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins","volume":"141","author":"Taylor","year":"1980","journal-title":"J Infect Dis"},{"key":"H88-2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(83)91036-X","article-title":"Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile -associated diarrhoea and colitis","volume":"2","author":"Teasley","year":"1983","journal-title":"Lancet"},{"key":"H89-2","first-page":"867","article-title":"Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis","volume":"80","author":"Tedesco","year":"1985","journal-title":"Am J Gastroenterol"},{"key":"H90-2","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1086\/342691","article-title":"Clostridium difficile -associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policy","volume":"35","author":"Thomas","year":"2002","journal-title":"Clin Infect Dis"},{"key":"H91-2","first-page":"57","article-title":"Bovine hyperimmune whey protein concentrate with specific biological activity as a replacement ingredient","author":"Thorig","year":"2001","journal-title":"Innov Food Technol"},{"key":"H92-2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/BF02133974","article-title":"Toxic megacolon complicating pseudomembranous colitis","volume":"38","author":"Trudel","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"H93-2","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0140-6736(89)92749-9","article-title":"Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients","volume":"1","author":"Tvede","year":"1989","journal-title":"Lancet"},{"key":"H94-2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1503\/cmaj.1040957","article-title":"Clostridium difficile infection in hospitals: a brewing storm","volume":"171","author":"Valiquette","year":"2004","journal-title":"Can Med Assoc J"},{"key":"H95-2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/jmm.0.45773-0","article-title":"Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data","volume":"54","author":"van Dissel","year":"2005","journal-title":"J Med Microbiol"},{"key":"H96-2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/IAI.62.2.384-389.1994","article-title":"Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection","volume":"62","author":"Warny","year":"1994","journal-title":"Infect Immun"},{"key":"H97-2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinids\/22.5.813","article-title":"Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile -associated diarrhea","volume":"22","author":"Wenisch","year":"1996","journal-title":"Clin Infect Dis"},{"key":"H98-2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/jac\/dkh176","article-title":"Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea","volume":"53","author":"Wilcox","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"H99-2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0195-6701(98)90062-7","article-title":"Recurrence of symptoms in Clostridium difficile infection \u2013 relapse or reinfection?","volume":"38","author":"Wilcox","year":"1998","journal-title":"J Hosp Infect"},{"key":"H100-2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/jac\/dkh278","article-title":"A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile -associated diarrhea","volume":"54","author":"Wullt","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"H101-2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/00365540310010985","article-title":"Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile- associated diarrhoea: a double-blind, placebo-controlled trial","volume":"35","author":"Wullt","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"H102-2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1128\/JCM.16.6.1096-1101.1982","article-title":"Investigation of an outbreak of antibiotic-associated colitis by various typing methods","volume":"16","author":"W\u00fcst","year":"1982","journal-title":"J Clin Microbiol"},{"key":"H103-2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0016-5085(85)90206-9","article-title":"Antibiotic-associated colitis due to Clostridium difficile : double-blind comparison of vancomycin with bacitracin","volume":"89","author":"Young","year":"1985","journal-title":"Gastroenterology"},{"key":"H104-2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2307\/30147052","article-title":"Risk factors for Clostridium difficile cytotoxin-positive diarrhea after control for horizontal transmission","volume":"12","author":"Zimmerman","year":"1991","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.45753-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T08:34:44Z","timestamp":1625387684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.45753-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,1]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2,1]]}},"URL":"https:\/\/doi.org\/10.1099\/jmm.0.45753-0","relation":{},"ISSN":["0022-2615","1473-5644"],"issn-type":[{"value":"0022-2615","type":"print"},{"value":"1473-5644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,1]]}}}